Agendia Participating in European Personalized Medicine Projects for Breast, Colon Cancer

Agendia received $1.8 million from the European Union's 7th Framework Program to develop new molecular diagnostics that will inform personalized treatment approaches for breast and colon cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.